ESC 365 - Clinical impact of early TTR stabilisation

ESC2025 Premium Access

Clinical impact of early TTR stabilisation

Session: The importance of transthyretin (TTR): optimising outcomes in ATTRv-CM and ATTRwt-CM

Topic: Cardiac Amyloidosis

Speaker: Doctor A. Masri (Portland, US)

Sponsored by BridgeBio

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Ahmad Masri

Oregon Health & Science University Medical Group, Portland (United States of America)

18 presentations

1 follower

4 more presentations in this session

Introduction

Speaker: Professor M. Fontana (London, GB)

TTR's vital role throughout the body

Speaker: Professor M. Gertz (Rochester, US)

TTR stabilisation for the management of variant and Wild-Type ATTR-CM

Speaker: Doctor N. Sarswat (Chicago, US)

Q&A

Access the full session

The importance of transthyretin (TTR): optimising outcomes in ATTRv-CM and ATTRwt-CM

Speakers: Doctor A. Masri, Professor M. Fontana, Professor M. Gertz, Doctor N. Sarswat

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources